C‐peptide antioxidant adaptive pathways in β cells and diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Internal Medicine

• Publication date

  2017-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/joim.12522PMID 27251308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.

  2015cited by this paper
• C‐peptide: should we be testing this routinely in the Type 1 diabetes clinic?

  2015cited by this paper
• C-peptide: new findings and therapeutic possibilities.

  2015cited by this paper
• Low levels of C‐peptide have clinical significance for established Type 1 diabetes

  2015cited by this paper
• C‐peptide evolution: Generation from few structural restrictions of bioactivities not necessarily functional

  2015cited by this paper
• Heterogeneity in recent‐onset type 1 diabetes – a clinical trial perspective

  2015cited by this paper
• Autocrine C‐peptide mechanism underlying INS1 beta cell adaptation to oxidative stress

  2014cited by this paper
• Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

  2014cited by this paper
• Evolutionary history and metabolic insights of ancient mammalian uricases

  2014cited by this paper
• Physiological effects and therapeutic potential of proinsulin C-peptide.

  2014cited by this paper
• The structure, molecular interactions and bioactivities of proinsulin C-peptide correlate with a tripartite molecule

  2014cited by this paper
• Age‐dependent decline of β‐cell function in type 1 diabetes after diagnosis: a multi‐centre longitudinal study

  2014cited by this paper
• Islet NADPH oxidase activity modulates β-cell mass and endocrine function in rats with fructose-induced oxidative stress.

  2014cited by this paper
• RNA Sequencing Identifies Dysregulation of the Human Pancreatic Islet Transcriptome by the Saturated Fatty Acid Palmitate

  2014cited by this paper
• Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids

  2014cited by this paper
• The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

  2013cited by this paper
• Can C‐peptide mediated anti‐inflammatory effects retard the development of microvascular complications of type 1 diabetes?

  2013cited by this paper
• Sugar, Uric Acid, and the Etiology of Diabetes and Obesity

  2013cited by this paper
• C-Peptide Activates AMPKα and Prevents ROS-Mediated Mitochondrial Fission and Endothelial Apoptosis in Diabetes

  2013cited by this paper
• Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome

  2013cited by this paper
• Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?

  2013cited by this paper
• Role of pancreatic β‐cell death and inflammation in diabetes

  2013cited by this paper
• C-Peptide Reduces Mitochondrial Superoxide Generation by Restoring Complex I Activity in High Glucose-Exposed Renal Microvascular Endothelial Cells

  2012cited by this paper
• C-Peptide Prevents Hyperglycemia-Induced Endothelial Apoptosis Through Inhibition of Reactive Oxygen Species–Mediated Transglutaminase 2 Activation

  2012cited by this paper
• The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

  2012cited by this paper
• Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay

  2012cited by this paper
• Type 2 diabetes as an inflammatory disease

  2011cited by this paper
• Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake.

  2011cited by this paper
• Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration

  2011cited by this paper
• Oxidative Stress and Redox Modulation Potential in Type 1 Diabetes

  2011cited by this paper
• Role of endogenous ROS production in impaired metabolism-secretion coupling of diabetic pancreatic β cells.

  2011cited by this paper
• C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia

  2011cited by this paper
• C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock.

  2011cited by this paper
• C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells

  2011cited by this paper
• C‐peptide and long‐term complications of diabetes

  2011cited by this paper
• Monocyte Gene-Expression Profiles Associated With Childhood-Onset Type 1 Diabetes and Disease Risk: A Study of Identical Twins

  2010cited by this paper
• Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β‐cells

  2010cited by this paper
• Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene.

  2010cited by this paper
• Diabetes is a proinflammatory state: a translational perspective

  2010cited by this paper
• Peroxisome-Generated Hydrogen Peroxide as Important Mediator of Lipotoxicity in Insulin-Producing Cells

  2010cited by this paper
• Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein

  2010cited by this paper
• Transient Oxidative Stress Damages Mitochondrial Machinery Inducing Persistent β-Cell Dysfunction*

  2009cited by this paper
• Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients

  2009cited by this paper
• C‐peptide in the natural history of type 1 diabetes

  2009cited by this paper
• Glucolipotoxicity: fuel excess and beta-cell dysfunction.

  2008cited by this paper
• Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.

  2008cited by this paper
• Glucolipotoxicity : Fuel Excess and-Cell Dysfunction

  2008cited by this paper
• Sustained IL‐1α, IL‐4, and IL‐6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus

  2008cited by this paper
• Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κB pathway

  2008cited by this paper
• Islet adaptive changes to fructose-induced insulin resistance: beta-cell mass, glucokinase, glucose metabolism, and insulin secretion.

  2008cited by this paper
• Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells.

  2008cited by this paper
• Mammalian hibernation: a naturally reversible model for insulin resistance in man?

  2008cited by this paper
• Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.

  2007cited by this paper
• Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice

  2007cited by this paper
• Effects of C‐peptide on isolated human pancreatic islet cells

  2007cited by this paper
• Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children.

  2007cited by this paper
• Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion

  2007cited by this paper
• C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells.

  2006cited by this paper
• A causal role for uric acid in fructose-induced metabolic syndrome.

  2006cited by this paper
• Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.

  2006cited by this paper
• Nicotinamide nucleotide transhydrogenase: a link between insulin secretion, glucose metabolism and oxidative stress.

  2006cited by this paper
• The rise and fall of insulin secretion in type 1 diabetes mellitus

  2006cited by this paper
• C-Peptide Signals via Gαi to Protect against TNF-α–Mediated Apoptosis of Opossum Kidney Proximal Tubular Cells

  2006cited by this paper
• C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.

  2005cited by this paper
• The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.

  2005cited by this paper
• Natural history of beta-cell function in type 1 diabetes.

  2005cited by this paper
• Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions

  2005cited by this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cited by this paper
• Separate functional features of proinsulin C-peptide

  2005cited by this paper
• Two independent mutational events in the loss of urate oxidase during hominoid evolution

  2004cited by this paper
• Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia

  2004cited by this paper
• β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes

  2004cited by this paper
• Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.

  2004cited by this paper
• Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes*

  2004cited by this paper
• Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.

  2003cited by this paper
• A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

  2003cited by this paper
• Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.

  2003cited by this paper
• C‐peptide enhances insulin‐mediated cell growth and protection against high glucose–induced apoptosis in SH‐SY5Y cells

  2003cited by this paper
• The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

  2003cited by this paper
• Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans*

  2003cited by this paper
• Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?

  2002cited by this paper
• Macrophages from High‐Risk HLA‐DQB1*0201/*0302 Type 1 Diabetes Mellitus Patients are Hypersensitive to Lipopolysaccharide Stimulation

  2002cited by this paper
• Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.

  2002cited by this paper
• Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes?

  2002cited by this paper
• Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation.

  2001cited by this paper
• NF-κB: a key role in inflammatory diseases

  2001cited by this paper
• Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.

  2001cited by this paper
• C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat

  2001cited by this paper
• High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

  2000cited by this paper
• Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

  2000cited by this paper
• Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb

  2000cited by this paper
• Oxidative stress in families of type 1 diabetic patients: further evidence.

  2000cited by this paper
• Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

  2000cited by this paper
• C‐peptide inhibits leukocyte‐endothelium interaction in the microcirculation during acute endothelial dysfunction

  2000cited by this paper
• Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

  1999cited by this paper
• Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type 1 diabetes with no clinical vascular disease

  1999cited by this paper
• Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

  1998cited by this paper
• Effects of C-peptide on renal function at the early stage of experimental diabetes.

  1998cited by this paper
• Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells

  1997cited by this paper
• Ascorbate metabolism and its regulation in animals.

  1997cited by this paper

• C-peptide and epicardial adipose tissue in dialysis-dependent chronic kidney disease patients

  2025cites this paper
• Dynamic OGTT-derived C-peptide trajectories for metabolic heterogeneity and adverse pregnancy outcomes in gestational diabetes mellitus: a nested case‒control study

  2025cites this paper
• The role of metal ion metabolism in the pathogenesis of diabetes and associated complications

  2025cites this paper
• Dissecting the molecular landscape of Parkinson’s disease and Parkinson’s disease dementia using highly efficient snRNA-seq (HIF-snRNA-seq)

  2025cites this paper
• High-Accuracy Identification and Structure-Activity Analysis of Antioxidant Peptides via Deep Learning and Quantum Chemistry

  2025cites this paper
• Therapeutic targets in diabetic peripheral neuropathy: heat shock proteins

  2025cites this paper
• Correlation between C-peptide and diabetic retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study

  2025cites this paper
• Amphibians as a source of bioactive antioxidant peptides: Emerging insights and therapeutic potential

  2025cites this paper
• Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment

  2024cites this paper
• Xenogenic Engraftment of Human-Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-Pig Model

  2024cites this paper
• Exploring the Role of Vitamin D2, Parathyroid Hormone, and C-Peptides as Biomarkers in Diabetic Neuropathy Development

  2024cites this paper
• Potent anti-inflammatory and anti-apoptotic activities of electrostatically complexed C-peptide nanospheres ameliorate diabetic nephropathy.

  2024cites this paper
• The role of C-peptide in diabetes and its complications: an updated review

  2023influential citation
• Antioxidant peptides, the guardian of life from oxidative stress

  2023cites this paper
• The Beneficial Effects of C-peptide for Diabetic Encephalopathy

  2023cites this paper
• The HbA1c/C-Peptide Ratio is Associated With the No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction

  2023cites this paper
• Vanillic acid potentiates insulin secretion and prevents pancreatic β-cells cytotoxicity under H_2O_2-induced oxidative stress

  2022cites this paper
• How low is really low? Comparison of two C‐peptide assays to establish residual C‐peptide production in type 1 diabetes

  2022cites this paper
• In vitro and in vivo studies of the antidiabetic potential of Red Sea sponge-associated fungus “Aspergillus unguis” isolate SP51-EGY with correlations to its chemical composition

  2022cites this paper
• An Untargeted Lipidomics Study of Acute Ischemic Stroke with Hyperglycemia Based on Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry

  2022cites this paper
• A homogeneous enzyme-free ratiometric immunoassay for the determination of C-peptide.

  2022cites this paper
• Fasting and meal‐stimulated serum C‐peptide in long‐standing type 1 diabetes mellitus

  2022cites this paper
• A Ratiometric Fluorescence Immunoassay for the Detection of C-Peptide

  2021cites this paper
• Exposure to fine particulate matter promotes platelet activation and thrombosis via obesity-related inflammation.

  2021cites this paper
• Autocrine C‐peptide protects INS1 β cells against palmitic acid‐induced oxidative stress in peroxisomes by inducing catalase

  2020cites this paper
• C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes

  2020cites this paper
• Research Progress of C-Peptide and Its Physiological Function

  2020cites this paper
• Insights into the physiology of C-peptide.

  2020cites this paper
• Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection

  2020cites this paper
• Protective effects of either C‐peptide or l‐arginine on pancreatic β‐cell function, proliferation, and oxidative stress in streptozotocin‐induced diabetic rats

  2018cites this paper
• Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.

  2018cites this paper
• Curcuma longa L. extract improves the cortical neural connectivity during the aging process

  2017cites this paper
• Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets.

  2017cites this paper
• C‐peptide and the pathophysiology of microvascular complications of diabetes

  2017cites this paper
• C‐peptide prevents NF‐κB from recruiting p300 and binding to the inos promoter in diabetic nephropathy

  2017cites this paper
• World Journal of Diabetes

  year unknowncites this paper